U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07041385) titled 'Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women' on June 19.
Brief Summary: This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence exists in our local setting.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Preeclampsia (PE)
Intervention:
DRUG: Aspirin Tablets
This study aims to evaluate the effectiveness of 75 mg aspirin ve...